Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,900 | 2 | 55.2% |
| Food and Beverage | $1,168 | 50 | 33.9% |
| Travel and Lodging | $373.74 | 5 | 10.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $2,462 | 14 | $0 (2024) |
| Davol Inc. | $136.79 | 2 | $0 (2017) |
| Daiichi Sankyo Inc. | $124.61 | 6 | $0 (2022) |
| PFIZER INC. | $121.41 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $112.13 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $107.30 | 6 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $91.97 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $46.21 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41.65 | 3 | $0 (2019) |
| Eisai Inc. | $28.49 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $168.67 | 9 | PFIZER INC. ($53.01) |
| 2023 | $146.31 | 9 | Lilly USA, LLC ($66.10) |
| 2022 | $102.45 | 7 | Astellas Pharma US Inc ($35.18) |
| 2021 | $74.19 | 4 | Astellas Pharma US Inc ($40.03) |
| 2020 | $128.01 | 8 | Astellas Pharma US Inc ($32.09) |
| 2019 | $282.80 | 7 | Janssen Pharmaceuticals, Inc ($91.97) |
| 2018 | $13.05 | 1 | Abbott Laboratories ($13.05) |
| 2017 | $2,526 | 12 | Lilly USA, LLC ($2,366) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Neurology | ||||||
| 08/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: VACCINES | ||||||
| 07/15/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: ADHD | ||||||
| 05/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: PAIN | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Gastroenterology | ||||||
| 01/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 11/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Gastroenterology | ||||||
| 10/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 09/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 09/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Diabetes | ||||||
| 07/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | EAGLE PHARMACEUTICALS, INC. | BARHEMSYS (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Post Operative Nausea and Vomiting | ||||||
| 04/13/2023 | Supernus Pharmaceuticals, Inc. | HYLENEX RECOMBINANT (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: OPTHALMOLOGY | ||||||
| 02/02/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes | ||||||
| 10/27/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Urology | ||||||
| 06/29/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Urology | ||||||
| 05/25/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/24/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/13/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/21/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 160 | 167 | $68,000 | $10,092 |
| 2021 | 4 | 467 | 674 | $317,365 | $46,545 |
| 2020 | 1 | 13 | 16 | $8,343 | $1,061 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 73 | 76 | $28,750 | $4,144 | 14.4% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 44 | 46 | $17,100 | $2,639 | 15.4% |
| 00732 | Anesthesia for procedure on gallbladder, pancreas, or liver using an endoscope | Facility | 2023 | 14 | 15 | $7,500 | $1,145 | 15.3% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 16 | 17 | $7,050 | $1,083 | 15.4% |
| 00520 | Anesthesia for other closed procedure on chest | Facility | 2023 | 13 | 13 | $7,600 | $1,081 | 14.2% |
| 00142 | Anesthesia for lens surgery | Facility | 2021 | 382 | 586 | $260,410 | $37,906 | 14.6% |
| 00103 | Anesthesia for procedure on eyelid | Facility | 2021 | 47 | 48 | $28,027 | $4,245 | 15.1% |
| 00160 | Anesthesia for procedure on nose and sinus | Facility | 2021 | 20 | 20 | $17,779 | $2,722 | 15.3% |
| 00140 | Anesthesia for procedure on eye | Facility | 2021 | 18 | 20 | $11,150 | $1,671 | 15.0% |
| 00142 | Anesthesia for lens surgery | Facility | 2020 | 13 | 16 | $8,343 | $1,061 | 12.7% |
About Dr. Samuel King, M.D
Dr. Samuel King, M.D is a Anesthesiology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235314998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel King, M.D has received a total of $3,442 in payments from pharmaceutical and medical device companies, with $168.67 received in 2024. These payments were reported across 57 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($1,900).
As a Medicare-enrolled provider, King has provided services to 640 Medicare beneficiaries, totaling 857 services with total Medicare billing of $57,697. Data is available for 3 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Anesthesiology, Anesthesiology
- Location Fort Wayne, IN
- Active Since 12/31/2007
- Last Updated 03/12/2025
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1235314998
Products in Payments
- JARDIANCE (Drug) $2,315
- INJECTAFER (Drug) $124.61
- TRELEGY ELLIPTA (Drug) $112.13
- DAV-VENTRALIGHT (Device) $93.06
- TRULICITY (Drug) $92.68
- XARELTO (Drug) $91.97
- MOUNJARO (Drug) $82.83
- MYRBETRIQ (Drug) $72.12
- DAV-Phasix (Device) $43.73
- PREVNAR - 13 (Biological) $39.65
- Myrbetriq (Drug) $35.18
- ELIQUIS (Drug) $28.75
- XIFAXAN (Drug) $28.72
- Leqembi (Drug) $28.49
- SCS IPGs (Device) $24.37
- UBRELVY (Drug) $23.46
- GATTEX (Drug) $19.67
- VYNDAMAX (Drug) $18.40
- NURTEC ODT (Drug) $18.23
- Dyanavel XR (Drug) $17.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Fort Wayne
Dr. Daniel Nolan, Md, MD
Anesthesiology — Payments: $67,672
Zachary Biehl, M.d, M.D
Anesthesiology — Payments: $13,996
Dr. Kenneth Austin, M.d, M.D
Anesthesiology — Payments: $11,520
Dr. Nida Aziz, D.o, D.O
Anesthesiology — Payments: $6,474
Dr. Jared Coffman, Md, MD
Anesthesiology — Payments: $4,072
Dr. Tyler Keena, M.d, M.D
Anesthesiology — Payments: $3,250